Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study
Marie Selvy(Institut de Recherche en Santé Digestive), David Balayssac(Inserm), Aurélie Cabrespine(Centre Hospitalier Universitaire de Clermont-Ferrand), Carine Chaleteix(Centre Hospitalier Universitaire de Clermont-Ferrand), Daniel P. Nguyen(Memorial Sloan Kettering Cancer Center), Nicolas Kerckhove(Centre Hospitalier Universitaire de Clermont-Ferrand), Richard Lemal(Université Clermont Auvergne), Martin Soubrier(Centre Hospitalier Universitaire de Clermont-Ferrand), Fabrice Giraudet(Centre National de la Recherche Scientifique), Fantine Barreau(Centre Hospitalier Universitaire de Clermont-Ferrand), Jacques‐Olivier Bay(Centre Hospitalier Universitaire de Clermont-Ferrand), Jérôme Busserolles(Inserm)
Cited by 53
Related Papers
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
|Arthritis & Rheumatism|2002|574
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Hypervulnerability to Sound Exposure through Impaired Adaptive Proliferation of Peroxisomes
|Cell|2015|218
Importance of Binaural Hearing
|Audiology and Neurotology|2015|166
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no‐treatment study
|American Journal of Hematology|2015|148